top of page
Dr. Brad McGregor on the BackTable Tumor Board Podcast

Dr. Brad McGregor

Oncologist

2 Podcasts on BackTable

Dr. Brad McGregor is a medical oncologist and the Director of Clinical Research at the Lank Center of Genitourinary Oncology in Boston, Massachusetts.

Learn from the experiences and expertise of Dr. Brad McGregor and other leading voices in your specialty on the BackTable app.

Urothelial Carcinoma: Understanding ctDNA & Precision Medicine
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Urology

Episode # 287  •  30 Jan 2026

Urothelial Carcinoma: Understanding ctDNA & Precision Medicine

Is the era of cisplatin over, or are we simply becoming more precise about who benefits from it? As perioperative strategies in bladder cancer continue to evolve, emerging tools like circulating tumor DNA (ctDNA) are playing a bigger role in how clinicians assess recurrence risk and tailor treatment. In this episode of BackTable Tumor Board, host Alan Tan, medical oncologist at Vanderbilt-Ingram Cancer Center, is joined by bladder cancer experts Dr. Amanda Nizam and Dr. Brad McGregor to discuss recent advances in the diagnosis and treatment of urothelial carcinoma.

More from Dr. Brad McGregor

Loading recent podcasts…

About

Dr. Bradley A. McGregor is the Director of Clinical Research for the Lank Center of Genitourinary Oncology serving as a Medical Oncologist specializing in genitourinary malignancies at the Dana-Farber Cancer Institute. Completing is undergraduate and medical school education at Tufts University; he then joined the United States Air Force at the San Antonio Uniformed Services Health Education Consortium. While in the military, he completed his post-graduate training in internal medicine, medical oncology and hematology. While in the uniformed services, he provided oncologic care to active duty members, their family members and retirees across the spectrum of benign hematology and medical oncology in San Antonio, TX and northern California at Travis Air Force Base. He served in a multitude of roles including scientific member of the IRB, faculty for the Uniformed Services University of Health Sciences, clinical director and as the program director for the Transitional Year program. In addition, he served in Afghanistan as the Deputy Commander for the NATO led Medical Training Advisory Group where he mentored the Afghan physicians. Reaching the rank of Lieutenant Colonel and receiving the Meritorious Service medal, Dr. McGregor left the Air Force in July of 2016 and came to Dana-Farber. He is actively involved in clinical research in GU malignancies serving as primary investigator for several ongoing trials.

Visit Dana-Farber Cancer Institute to learn more about Dr. Brad McGregor.

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page